Discussion
NF1, cognitive impairment
RASOPATHIES
The SynCoRAS study is targeting impairments in synaptic plasticity and cognitive impairment, one of the main health problems of patients with RASopathies. This has been done by the authors successfully for Lovastatin in NF1 before [